SOLUZIONE PER DIALISI PERITONEALE FME Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

soluzione per dialisi peritoneale fme

fresenius medical care deutschland gmbh - soluzioni isotoniche - soluzioni isotoniche

SOLUZIONE PER DIALISI PERITONEALE FRESENIUS MEDICAL CARE DEUTSCHLAND Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

soluzione per dialisi peritoneale fresenius medical care deutschland

fresenius medical care deutschland gmbh - soluzioni isotoniche - soluzioni isotoniche

SOLUZIONE CARDIOPLEGICA BIOINDUSTRIA L.I.M. Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

soluzione cardioplegica bioindustria l.i.m.

bioindustria laboratorio italiano medicinali s.p.a. - soluzioni cardioplegiche - soluzioni cardioplegiche

Plerixafor Accord Unione Europea - italiano - EMA (European Medicines Agency)

plerixafor accord

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimolanti, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

SOLUZIONE CARDIOPLEGICA Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

soluzione cardioplegica

fresenius kabi italia s.r.l. - soluzioni cardioplegiche - soluzioni cardioplegiche

INFLUVAC S TETRA Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

influvac s tetra

viatris healthcare limited - influenza, antigene purificato - influenza, antigene purificato

Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Unione Europea - italiano - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influenza virus antigeni di superficie (emoagglutinina e neuraminidasi) del ceppo a/vietnam/1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccini - immunizzazione attiva contro il sottotipo h5n1 del virus dell'influenza a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.